MoneyWorks4Me

Anuh Pharma - Quaterly Results

07 Nov 2022 Evaluate
The Revenue for the quarter ended  September 2022 of Rs. 1150.70 millions grew by 5.82 % from Rs. 1087.40 millions.A slim rise of 15.34% was recorded in the Net profit for the quarter ended September 2022 to Rs. 99.16  millions  From Rs. 85.97 millions.OP of the company witnessed a marginal growth to 154.38 millions from 143.88 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 1150.70 1087.40 5.82 2314.47 2260.12 2.40 4866.46 4319.60 12.66
Other Income 20.10 19.05 5.51 29.65 38.29 -22.56 51.97 105.38 -50.68
PBIDT 154.38 143.88 7.30 275.78 246.70 11.79 520.43 551.22 -5.59
Interest 1.06 3.85 -72.47 1.66 5.61 -70.41 9.61 14.94 -35.68
PBDT 153.32 140.03 9.49 274.12 241.09 13.70 510.82 536.28 -4.75
Depreciation 24.42 29.70 -17.78 48.60 59.61 -18.47 119.60 150.76 -20.67
PBT 128.90 110.33 16.83 225.52 181.48 24.27 391.22 385.52 1.48
TAX 29.74 24.36 22.09 53.01 39.60 33.86 85.61 101.15 -15.36
Deferred Tax -1.16 -2.34 -50.43 -2.49 -4.50 -44.67 -9.95 6.50 -253.08
PAT 99.16 85.97 15.34 172.51 141.88 21.59 305.61 284.37 7.47
Equity 250.56 250.56 0.00 250.56 250.56 0.00 250.56 250.56 0.00
PBIDTM(%) 13.42 13.23 1.40 11.92 10.92 9.16 10.69 12.76 -16.20
Peers
Company Name CMP
Sun Pharma. Inds. 1833.80
Dr. Reddys Labs. 1164.80
Cipla 1356.45
Lupin 2079.40
Zydus Lifesciences 1114.20
View more..